Genizon BioSciences
Discovering genes and biomarkers in common diseases with innovative technology and access to the Quebec Founder Population.
Discovering genes and biomarkers in common diseases with innovative technology and access to the Quebec Founder Population.
Genizon BioSciences is a biotechnology company founded in 1999 with a focus on discovering genes and biomarkers in common diseases. Leveraging innovative technology and access to the Quebec Founder Population, the company conducts genome wide association studies (GWAS) to identify genetic factors contributing to various medical conditions. In January 2008, they secured a significant $30.81M Series E investment from leading investors including HBM Healthcare Investments, Investissement Desjardins, Biotech Turnaround Fund (BTF), and BioFund Management. Genizon Biosciences operates within the biotechnology, life sciences, and medical devices industries, positioning itself at the forefront of genetic research and personalized medicine. With a dedication to advancing healthcare through genetic insights, the company remains poised for continued growth and impact in the biotech sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series E | $30.81M | 4 |
|
01 Jan 2008 |
| Series D | $10.00M | 2 | Pfizer Venture Investments, Biotech Turnaround Fund (BTF) | 05 Feb 2007 |
| Venture Round | $12.00M | 5 |
|
29 Mar 2006 |
| Series B | $11.10M | 4 |
|
13 Dec 2004 |
| Venture Round | $11.15M | 3 |
|
07 Jan 2004 |
No recent news or press coverage available for Genizon BioSciences.
We care about your data, and we'd love to use cookies make your experience better.